‘Chemotherapy Kills People, Not Cancer’,Posted: February 20, 2017
According to former Professor of Medical Physics and Physiology at the University of California, Berkeley, Dr. Hardin B. Jones, it’s chemotherapy that kills people rather than cancer. As the professor explains, patients who refuse chemotherapy live, on average, 12 ½ years longer than patients who take the treatment. In his point of view, chemotherapy is only prescribed for profit taken that treatments cost between $300,000 and $1,000,000.
Statistical data reveal that on average 1 in 2 men and 1 in 3 women develop cancer during their life. What’s worse is that present-day cancer treatments are often unsuccessful and only aggravate the symptoms of the disease. According to the Berkeley doctor, chemotherapy is ineffective in 97% of the cases.
Dr. Hardin B. Jones has studied the life expectancy of cancer patients for more than 25 years, after which time he has come to the conclusion that chemotherapy does more harm than good. The research made the professor realize that ‘leading edge’ cancer treatment is a sham.
On the other hand, Dr. Jones is well-aware that cancer is a billion-dollar industry. “People who refused chemotherapy treatment live on average 12 and a half years longer than people who are undergoing chemotherapy,” said Dr. Jones of his research, published in the New York Academy of Science.
“People who accepted chemotherapy die within three years of diagnosis, a large number dies immediately after a few weeks.” As seen by Dr. Jones, the only reason chemotherapy is prescribed to patients is because the medical industry can profit from it, which is quite plausible as cancer treatment runs, on average, from $300,000 – $1,000,000.
“Patients with breast cancer who reject conventional therapy live four times longer than those who follow the system. So this is something that you will not hear in the mass media, which will continue to carry the myth that the best chemotherapy drug in the fight against cancer!”
The US invests more in healthcare than any other high-income nation in the world. Still, ‘costly’ diseases continue to rise in prevalence, resulting in a shorter life expectancy. On the other hand, the importance of preventative medicine is completely disregarded by both mainstream media and the allopathic healthcare system.
Overall health and longevity largely depend on a healthy diet, regular exercise, positive thoughts, no stress, and fulfilled social life. Plus, there are powerful natural medicines, including cannabis oil, that have been more effective in treatment of life-threatening diseases than conventional treatments.
Statistics at a Glance
- In 2016, an estimated 1,685,210 new cases of cancer were diagnosed in the United States, 595,690 of whom will die from the disease.
- The most prevalent cancers in 2016 are breast, lung and bronchus cancer, prostate cancer, colon and rectum cancer, bladder cancer, skin melanoma, non-Hodgkin lymphoma, thyroid cancer, kidney and renal pelvis cancer, leukemia, endometrial cancer, and pancreatic cancer.
- Cancer incidence – the number of new cancer cases is 454.8 per 100,000 annually (based on 2008-2012 statistics).
- Cancer mortality – the number of cancer deaths is 171.2 per 100,000 on an annual level (based on 2008-2012 statistics). Cancer mortality is higher in men than women (207.9 per 100,000 men and 145.4 per 100,000 women).
- Cancer mortality is highest in African American men (261.5 per 100,000) and lowest in Asian/Pacific Islander women (91.2 per 100,000). The evidence is based on 2008-2012 statistics.
- In 2014, the number of people living beyond a cancer diagnosis reached nearly 14.5 million and is expected to rise to almost 19 million by 2024. Approximately 39.6% of men and women will be diagnosed with cancer at some point during their lifetimes.
- In 2014, an estimated 15,780 children and adolescents, ages 0 to 19, were diagnosed with cancer and 1,960 died of the disease.
- National expenditures for cancer care in the US totaled $125 billion in 2010 and could reach $156 billion in 2020.